• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性冠状动脉完全闭塞患者最佳药物治疗与经皮冠状动脉介入治疗的长期临床结局比较。

Long-term clinical outcomes of optimal medical therapy vs. successful percutaneous coronary intervention for patients with coronary chronic total occlusions.

机构信息

Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian City, People's Republic of China.

Department of Cardiology, The First People's Hospital of Changde, Hunan province, People's Republic of China.

出版信息

Hellenic J Cardiol. 2018 Sep-Oct;59(5):281-287. doi: 10.1016/j.hjc.2018.03.005. Epub 2018 Mar 30.

DOI:10.1016/j.hjc.2018.03.005
PMID:29605686
Abstract

OBJECTIVES

There are little data on the long-term clinical outcomes of optimal medical therapy (OMT) compared with successful percutaneous coronary intervention (PCI) in patients with chronic total occlusions (CTOs).

METHODS

A total of 388 patients with ≥1 CTO were enrolled from January 2008 to December 2010. 62 patients were excluded, and 326 patients were divided into an OMT group (n = 125) and PCI group (n = 201) according to the initial treatment strategy. Propensity-score matching was also done to adjust for baseline characteristics. The primary outcome was major adverse cardiac event (MACE), included cardiac death, recurrent myocardial infarction, and repeated revascularization.

RESULTS

After a mean follow-up of 47.2 ± 20.0 months, there was no significant difference between the two groups with respect to the prevalence of MACE (successful PCI vs. OMT: 29.6% vs. 21.9%, unadjusted hazard ratio [HR] 1.47, 95% confidence interval [CI] 0.95-2.28, p=0.085). After multivariate analyses, there were significant differences in the prevalence of MACE (adjusted HR 1.76, 95% CI 1.09-2.28, p=0.02) and repeated revascularization (2.14; 1.18-3.90, 0.01). In the propensity score-matched population (80 pairs), there were no significant differences in the prevalence of MACE (adjusted HR 1.89, 95% CI 0.96-3.71, p=0.06) and cardiac death (1.30, 0.44-3.80, 0.63) between groups.

CONCLUSION

In the treatment of patients with CTOs, successful PCI did not reduce the long-term risk of MACE compared with OMT.

摘要

目的

对于慢性完全闭塞(CTO)患者,与经皮冠状动脉介入治疗(PCI)相比,优化药物治疗(OMT)的长期临床结局数据较少。

方法

2008 年 1 月至 2010 年 12 月,共纳入 388 例至少有 1 例 CTO 的患者。排除 62 例患者,根据初始治疗策略将 326 例患者分为 OMT 组(n=125)和 PCI 组(n=201)。还进行了倾向评分匹配以调整基线特征。主要终点是主要不良心脏事件(MACE),包括心脏死亡、再发心肌梗死和再次血运重建。

结果

平均随访 47.2±20.0 个月后,两组 MACE 发生率(成功 PCI 与 OMT:29.6%与 21.9%,未调整的风险比[HR]1.47,95%置信区间[CI]0.95-2.28,p=0.085)无显著差异。多变量分析后,MACE 发生率(调整 HR 1.76,95%CI 1.09-2.28,p=0.02)和再次血运重建(2.14;1.18-3.90,0.01)有显著差异。在倾向评分匹配人群(80 对)中,MACE 发生率(调整 HR 1.89,95%CI 0.96-3.71,p=0.06)和心脏死亡(1.30,0.44-3.80,p=0.63)无显著差异。

结论

在 CTO 患者的治疗中,与 OMT 相比,成功 PCI 并不能降低长期 MACE 的风险。

相似文献

1
Long-term clinical outcomes of optimal medical therapy vs. successful percutaneous coronary intervention for patients with coronary chronic total occlusions.慢性冠状动脉完全闭塞患者最佳药物治疗与经皮冠状动脉介入治疗的长期临床结局比较。
Hellenic J Cardiol. 2018 Sep-Oct;59(5):281-287. doi: 10.1016/j.hjc.2018.03.005. Epub 2018 Mar 30.
2
Optimal medical therapy may be a better initial strategy in patients with chronic total occlusion of a single coronary artery.对于单支冠状动脉慢性完全闭塞的患者,优化药物治疗可能是更好的初始策略。
Int J Cardiol. 2016 May 1;210:56-62. doi: 10.1016/j.ijcard.2016.02.084. Epub 2016 Feb 16.
3
Successful recanalisation of coronary chronic total occlusions is not associated with improved cardiovascular survival compared with initial medical therapy.与初始药物治疗相比,成功再通冠状动脉慢性完全闭塞病变与改善心血管生存无关。
Scand Cardiovasc J. 2019 Dec;53(6):305-311. doi: 10.1080/14017431.2019.1645351. Epub 2019 Jul 24.
4
The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world.真实世界中成功的慢性完全闭塞经皮冠状动脉介入治疗对长期临床结局的影响。
BMC Cardiovasc Disord. 2021 Apr 15;21(1):182. doi: 10.1186/s12872-021-01976-w.
5
Five-Year Outcomes of Successful Percutaneous Coronary Intervention with Drug-Eluting Stents versus Medical Therapy for Chronic Total Occlusions.药物洗脱支架成功经皮冠状动脉介入治疗与药物治疗慢性完全闭塞病变的五年结局
Yonsei Med J. 2018 Jul;59(5):602-610. doi: 10.3349/ymj.2018.59.5.602.
6
Long-term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitus.比较有/无 2 型糖尿病的冠状动脉慢性完全闭塞患者药物治疗与血运重建成功后长期预后。
Cardiovasc Diabetol. 2020 Jul 4;19(1):100. doi: 10.1186/s12933-020-01087-4.
7
Two-year clinical outcomes of medical therapy vs. revascularization for patients with coronary chronic total occlusion.药物治疗与血运重建治疗冠状动脉慢性完全闭塞患者的两年临床结局比较
Hellenic J Cardiol. 2020 Jul-Aug;61(4):264-271. doi: 10.1016/j.hjc.2019.03.006. Epub 2019 Apr 3.
8
Medical therapy, percutaneous coronary intervention and prognosis in patients with chronic total occlusions.慢性完全闭塞患者的药物治疗、经皮冠状动脉介入治疗与预后
Heart. 2015 Dec;101(23):1907-14. doi: 10.1136/heartjnl-2015-308181. Epub 2015 Nov 9.
9
Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: A meta-analysis of randomized controlled trials and propensity score adjusted studies.慢性完全闭塞患者的最佳药物治疗与冠状动脉血运重建:随机对照试验和倾向评分调整研究的荟萃分析
Catheter Cardiovasc Interv. 2019 May 1;93(6):E320-E325. doi: 10.1002/ccd.28037. Epub 2018 Dec 13.
10
Periprocedural Myocardial Injury After Recanalization of Single Chronic Coronary Occlusion - A Propensity Score Analysis Comparing Long-Term Clinical Outcomes.单支慢性冠状动脉闭塞再通术后围手术期心肌损伤——一项比较长期临床结局的倾向评分分析
J Invasive Cardiol. 2017 Feb;29(2):63-67. Epub 2016 Nov 15.

引用本文的文献

1
Percutaneous Coronary Intervention versus Optimal Medical Therapy in Patients with Chronic Total Occlusion: A Meta-Analysis.慢性完全闭塞患者经皮冠状动脉介入治疗与最佳药物治疗的Meta分析
J Clin Med. 2024 May 15;13(10):2919. doi: 10.3390/jcm13102919.
2
Percutaneous coronary intervention versus optimal medical therapy for stable coronary artery disease: An umbrella review.经皮冠状动脉介入治疗与稳定型冠状动脉疾病的最佳药物治疗:一项伞状综述。
Heliyon. 2024 Mar 2;10(5):e27210. doi: 10.1016/j.heliyon.2024.e27210. eCollection 2024 Mar 15.
3
Prognostic Value of Fibrinogen-to-Albumin Ratio in Coronary Three-Vessel Disease.
纤维蛋白原与白蛋白比值在冠状动脉三支病变中的预后价值
J Inflamm Res. 2023 Dec 1;16:5767-5777. doi: 10.2147/JIR.S443282. eCollection 2023.
4
Systemic Immune-Inflammation Index Predicts Long-Term Outcomes in Patients with Three-Vessel Coronary Disease After Revascularization: Results from a Large Cohort of 3561 Patients.全身免疫炎症指数预测三支血管冠状动脉疾病患者血运重建后的长期预后:来自3561例患者的大型队列研究结果
J Inflamm Res. 2022 Sep 12;15:5283-5292. doi: 10.2147/JIR.S385990. eCollection 2022.
5
Revascularization of chronic total occlusion coronary artery and cardiac regeneration.慢性完全闭塞冠状动脉的血运重建与心脏再生
Front Cardiovasc Med. 2022 Aug 25;9:940808. doi: 10.3389/fcvm.2022.940808. eCollection 2022.
6
Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis.评估经皮冠状动脉介入治疗(PCI)与稳定型冠心病最佳药物治疗(ODT)的疗效和安全性:一项系统评价和荟萃分析。
J Thorac Dis. 2022 Apr;14(4):1183-1192. doi: 10.21037/jtd-22-222.
7
Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Prior Coronary Artery Bypass Graft: Current Evidence and Future Perspectives.既往接受冠状动脉旁路移植术患者的慢性完全闭塞性经皮冠状动脉介入治疗:当前证据与未来展望
Front Cardiovasc Med. 2022 Apr 11;9:753250. doi: 10.3389/fcvm.2022.753250. eCollection 2022.
8
Gender-Based Long-Term Outcomes After Revascularization for Three-Vessel Coronary Disease: A Propensity Score-Matched Analysis of a Large Cohort.基于性别对三血管病变血运重建后的长期结局:一项大型队列的倾向评分匹配分析。
Clin Interv Aging. 2022 Apr 19;17:545-554. doi: 10.2147/CIA.S362027. eCollection 2022.
9
Predictors of Adverse Events Among Chronic Total Occlusion Patients Undergoing Successful Percutaneous Coronary Intervention and Medical Therapy.成功行经皮冠状动脉介入治疗和药物治疗的慢性完全闭塞病变患者不良事件的预测因素。
Clin Interv Aging. 2021 Oct 14;16:1847-1855. doi: 10.2147/CIA.S337069. eCollection 2021.
10
Long-Term Outcomes of Successful Recanalization Compared With Optimal Medical Therapy for Coronary Chronic Total Occlusions in Patients With and Without Left Ventricular Systolic Dysfunction.左心室收缩功能障碍患者与非左心室收缩功能障碍患者冠状动脉慢性完全闭塞成功再通与最佳药物治疗的长期结局比较
Front Cardiovasc Med. 2021 Apr 20;8:654730. doi: 10.3389/fcvm.2021.654730. eCollection 2021.